- Home
- POAS vs ALEC Comparison
POAS vs ALEC Comparison
Compare POAS & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAS
- ALEC
- Stock Information
- Founded
- POAS 2017
- ALEC 2013
- Country
- POAS Singapore
- ALEC United States
- Employees
- POAS N/A
- ALEC N/A
- Industry
- POAS Industrial Machinery/Components
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- POAS Industrials
- ALEC Health Care
- Exchange
- POAS Nasdaq
- ALEC Nasdaq
- Market Cap
- POAS 114.0M
- ALEC 124.0M
- IPO Year
- POAS 2025
- ALEC 2019
- Fundamental
- Price
- POAS $3.88
- ALEC $1.25
- Analyst Decision
- POAS
- ALEC Hold
- Analyst Count
- POAS 0
- ALEC 9
- Target Price
- POAS N/A
- ALEC $3.40
- AVG Volume (30 Days)
- POAS 1.3M
- ALEC 5.5M
- Earning Date
- POAS 01-01-0001
- ALEC 11-06-2025
- Dividend Yield
- POAS N/A
- ALEC N/A
- EPS Growth
- POAS N/A
- ALEC N/A
- EPS
- POAS N/A
- ALEC N/A
- Revenue
- POAS $128,328.00
- ALEC $69,048,000.00
- Revenue This Year
- POAS N/A
- ALEC N/A
- Revenue Next Year
- POAS N/A
- ALEC $314.69
- P/E Ratio
- POAS N/A
- ALEC N/A
- Revenue Growth
- POAS N/A
- ALEC 12.26
- 52 Week Low
- POAS $3.70
- ALEC $0.87
- 52 Week High
- POAS $4.30
- ALEC $5.16
- Technical
- Relative Strength Index (RSI)
- POAS N/A
- ALEC 33.67
- Support Level
- POAS N/A
- ALEC $1.19
- Resistance Level
- POAS N/A
- ALEC $1.60
- Average True Range (ATR)
- POAS 0.00
- ALEC 0.14
- MACD
- POAS 0.00
- ALEC 0.03
- Stochastic Oscillator
- POAS 0.00
- ALEC 22.12
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.